Literature DB >> 1000422

Glucose and insulin metabolism in Friedreich's ataxia.

D Shapcott, S Melancon, R F Butterworth, K Khoury, R Collu, G Breton, G Geoffroy, B Lemieux, A Barbeau.   

Abstract

Our prospective survey of 50 ataxic patients confirms the previous finding of frequent clinical or chemical diabetes in Friedreich's ataxia. Eighteen percent of our typical cases have clinical diabetes and 40% at least an abnormal glucose tolerance curve. However, this finding does not appear to be specific to that form of ataxia. Furthermore, we have shown that most patients with ataxia have normal or low fasting insulin levels, but a hyperinsulinic response to a glucose load.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1000422     DOI: 10.1017/s0317167100025609

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  13 in total

1.  Biochemical and clinical studies of Friedreich's ataxia.

Authors:  P Purkiss; M Baraitser; O Borud; R A Chalmers
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-07       Impact factor: 10.154

Review 2.  Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities.

Authors:  Renata Santos; Sophie Lefevre; Dominika Sliwa; Alexandra Seguin; Jean-Michel Camadro; Emmanuel Lesuisse
Journal:  Antioxid Redox Signal       Date:  2010-09-01       Impact factor: 8.401

3.  Genetic data and natural history of Friedreich's disease: a study of 80 Italian patients.

Authors:  A Filla; G DeMichele; G Caruso; R Marconi; G Campanella
Journal:  J Neurol       Date:  1990-10       Impact factor: 4.849

4.  [Glutamate and GABA concentration in the brain and cerebrospinal fluid of rats treated with phosphatidylcholine].

Authors:  D Claus; J S Kim; J C Aschoff; H H Kornhuber
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1982

5.  Preclinical and manifest diabetes mellitus in young patients with Friedreich's ataxia: no evidence of immune process behind the islet cell destruction.

Authors:  E J Schoenle; E J Boltshauser; S Baekkeskov; M Landin Olsson; T Torresani; A von Felten
Journal:  Diabetologia       Date:  1989-06       Impact factor: 10.122

6.  Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich's ataxia.

Authors:  Giovanni Coppola; Daniele Marmolino; Daning Lu; Qing Wang; Miriam Cnop; Myriam Rai; Fabio Acquaviva; Sergio Cocozza; Massimo Pandolfo; Daniel H Geschwind
Journal:  Hum Mol Genet       Date:  2009-04-17       Impact factor: 6.150

7.  PGC-1alpha down-regulation affects the antioxidant response in Friedreich's ataxia.

Authors:  Daniele Marmolino; Mario Manto; Fabio Acquaviva; Paola Vergara; Ajay Ravella; Antonella Monticelli; Massimo Pandolfo
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

8.  Exclusion of the Friedreich ataxia gene from chromosome 19.

Authors:  S Chamberlain; C S Worrall; S South; J Shaw; M Farrall; R Williamson
Journal:  Hum Genet       Date:  1987-06       Impact factor: 4.132

9.  Central role and mechanisms of β-cell dysfunction and death in friedreich ataxia-associated diabetes.

Authors:  Miriam Cnop; Mariana Igoillo-Esteve; Myriam Rai; Audrey Begu; Yasmina Serroukh; Chantal Depondt; Anyishai E Musuaya; Ihsane Marhfour; Laurence Ladrière; Xavier Moles Lopez; Dionysios Lefkaditis; Fabrice Moore; Jean-Pierre Brion; J Mark Cooper; Anthony H V Schapira; Anne Clark; Arnulf H Koeppen; Piero Marchetti; Massimo Pandolfo; Décio L Eizirik; Françoise Féry
Journal:  Ann Neurol       Date:  2012-12       Impact factor: 10.422

10.  Friedreich ataxia (FA) associated with diabetes mellitus type 1 and hyperthrophic cardiomyopathy.

Authors:  Zoran Gucev; Velibor Tasic; Aleksandra Jancevska; Nada Popjordanova; Svetlana Koceva; Marija Kuturec; Vesna Sabolic
Journal:  Bosn J Basic Med Sci       Date:  2009-05       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.